ReviewActa gastroenterologica Latinoamericana
[Gastric Cancer Prevention: Latin American Context and Experience].
Review in Acta gastroenterologica Latinoamericana. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Optimized Amoxicillin Dosing is Associated with Higher Helicobacter pylori Eradication in Metabolic and Bariatric Surgery Candidates: A Retrospective Cohort Study.Obesity surgery · 2026Article
- The importance ofFrontiers in gastroenterology (Lausanne, Switzerland) · 2026Review
- Clinicopathological Profiles and Survival Outcomes of Patients with Gastric Cancer According to the Borrmann Endoscopic Classification: A Single-Center Retrospective Cohort Study.Medicina (Kaunas, Lithuania) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer is a multifactorial disease, and chronic Helicobacter pylori infection is one of its main causes. It receives little attention in the West, with few preventive policies, especially in countries such as Argentina, which is considered 'low risk.' But both in Argentina and in the United States, the population is heterogeneous, with permanent immigration from countries with high or intermediate risk, with the highest susceptibility in the male population. It is estimated that the incidence will increase due to the aging of the population. In recent years, new evidence for its prevention has emerged. The main strategy for primary prevention is the eradication of Helicobacter pylori, while secondary prevention for heterogeneous countries such as Argentina is based on the identification of risk groups, particularly those with the so-called precursor lesions of gastric cancer. This narrative review explores all these strategies with a 'strong bias' towards the situation in Argentina, Chile and Latin America.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.